Breaking News
Sort by:
Top Post
Experimental Cancer Drug May Slow Inflammation Linked to Heart Disease
An experimental drug already tested as a potential treatment for cancer, lung, and Alzheimer’s disease […]
Lucem Health™ Announces Innovation Collaborative to Bring AI/ML to the Front Lines of Healthcare
Lucem Health™ today launched the Lucem Health Innovation Collaborative, a partner program designed to move clinical […]
H1 Secures an Extension on Its Series C to Further Its Mission of Creating a Healthier Future Through the Use of Connected and Accessible Healthcare Data
H1, the connecting force for global healthcare professional, clinical, science, and research information, announced today […]
European Commission Approves Roche’s Tecentriq as Adjuvant Treatment for a Subset of People With Early-stage Non-small Cell Lung Cancer
Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced that the European Commission has approved Tecentriq® (atezolizumab) […]
Bayer’s Bluerock Therapeutics Establishes European Site for Cell Therapy Innovation
Bayer AG announced today that BlueRock Therapeutics LP (BlueRock), a clinical stage biopharmaceutical company and […]
Patients to Have Earlier Access to Cutting-edge Treatments on NHS
NHS patients in England will have early access to potentially life-saving and cutting-edge treatments thanks […]
Optibrium Expands UK Head Office With New Facilities on Cambridge Innovation Park
Optibrium™, a developer of software for drug discovery, today announced the expansion of its UK […]
Nosopharm and GNA NOW Announce Positive Results for the Late Preclinical Development of the First-in-class Antibiotic NOSO-502
Nosopharm, a biotechnology company specialized in exploring unconventional sources of antibiotics to discover new drugs […]
Axol Bioscience Introduces CiPA-validated Human Stem Cell-derived Ventricular Cardiomyocytes to Help Improve Drug Discovery
Axol Bioscience Ltd. (Axol), an established provider of iPSC-derived cells, media, and characterization services for life science […]
Insilico Medicine Raises $60 Million in Series D Financing to Advance Pipeline and Launch AI-powered Drug Discovery Robotics Laboratory
Insilico Medicine, a clinical-stage end-to-end artificial intelligence (AI)-driven drug discovery company, announced today that it […]
Ultima Genomics Collaborates with NVIDIA To Deliver $100 Genome Sequencing with AI and Accelerated Computing
Ultima Genomics, Inc. today unveiled a broad collaboration with NVIDIA that leverages AI-accelerated analysis across […]
- Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Read more
- Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS Read more
- DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Read more
- Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Read more
- Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Read more